Simulations Plus (NASDAQ:SLP) Now Covered by Analysts at Stephens

Stephens started coverage on shares of Simulations Plus (NASDAQ:SLP - Get Free Report) in a research note issued to investors on Friday, MarketBeat reports. The firm set an "overweight" rating and a $39.00 price target on the technology company's stock. Stephens' price objective would indicate a potential upside of 35.56% from the company's current price.

Several other equities analysts have also weighed in on the stock. BTIG Research dropped their price objective on shares of Simulations Plus from $60.00 to $50.00 and set a "buy" rating on the stock in a report on Thursday, October 24th. William Blair reiterated an "outperform" rating on shares of Simulations Plus in a report on Wednesday, November 6th. StockNews.com lowered Simulations Plus from a "hold" rating to a "sell" rating in a report on Monday, November 4th. Finally, KeyCorp assumed coverage on shares of Simulations Plus in a research note on Monday, July 29th. They issued an "overweight" rating and a $47.00 target price for the company. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $51.40.

Simulations Plus Trading Down 3.2 %

Simulations Plus stock traded down $0.94 during midday trading on Friday, reaching $28.77. The company's stock had a trading volume of 231,165 shares, compared to its average volume of 134,624. The stock has a market cap of $577.41 million, a PE ratio of 58.72 and a beta of 0.71. Simulations Plus has a 52 week low of $27.22 and a 52 week high of $51.22. The business has a 50-day moving average price of $31.31 and a 200-day moving average price of $39.04.

Simulations Plus (NASDAQ:SLP - Get Free Report) last released its quarterly earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.02. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The company had revenue of $18.70 million for the quarter, compared to analysts' expectations of $19.73 million. During the same period in the previous year, the business posted $0.18 earnings per share. The business's quarterly revenue was up 19.9% compared to the same quarter last year. As a group, research analysts predict that Simulations Plus will post 1.12 EPS for the current fiscal year.

Insider Activity at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $31.26, for a total value of $625,200.00. Following the completion of the sale, the director now directly owns 3,481,592 shares of the company's stock, valued at $108,834,565.92. This represents a 0.57 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders sold 60,750 shares of company stock valued at $1,905,655 over the last 90 days. Corporate insiders own 20.90% of the company's stock.

Institutional Trading of Simulations Plus

Large investors have recently made changes to their positions in the business. State Street Corp grew its holdings in shares of Simulations Plus by 4.7% in the third quarter. State Street Corp now owns 640,303 shares of the technology company's stock worth $20,503,000 after purchasing an additional 28,953 shares during the last quarter. Petrus Trust Company LTA purchased a new stake in Simulations Plus in the third quarter worth about $682,000. Verition Fund Management LLC grew its holdings in Simulations Plus by 120.5% during the 3rd quarter. Verition Fund Management LLC now owns 10,365 shares of the technology company's stock worth $332,000 after acquiring an additional 5,665 shares in the last quarter. BNP Paribas Financial Markets increased its position in Simulations Plus by 402.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 39,944 shares of the technology company's stock valued at $1,279,000 after purchasing an additional 32,002 shares during the period. Finally, Quantbot Technologies LP bought a new stake in shares of Simulations Plus in the 3rd quarter valued at about $59,000. 78.08% of the stock is currently owned by institutional investors.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.